The synergistic effect of FGF-21 and insulin on regulating glucose metabolism and its mechanism

Yaoxue Xuebao

Volumn 49, Issue 7, 2014, Pages 977-984

  Yu, Dan ^a   Sun, Cui Yu ^a   Sun, Guo Peng ^b   Ren, Gui Ping ^a   Ye, Xian Long ^a   Zhu, Sheng Long ^a   Wang, Wen Fei ^a   Xu, Peng Fei ^a   Li, Shu Jie ^a   Wu, Qiang ^a   Niu, Ze Shan ^a   Sun, Tian ^a   Liu, Ming Yao ^a   Li, De Shan ^a  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^b XINXIANG UNIVERSITY   (China)

Author keywords

Diabetes mellitus; Fibroblast growth factor 21; Insulin; Synergy

Indexed keywords

FIBROBLAST GROWTH FACTOR 21; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INSULIN; FIBROBLAST GROWTH FACTOR; GLUCOSE; GLUCOSE BLOOD LEVEL; SLC2A1 PROTEIN, MOUSE; SLC2A4 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; GLUCOSE ABSORPTION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEPG2 CELL LINE; INSULIN RESISTANCE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; HUMAN; LIVER; METABOLISM;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DRUG SYNERGISM; FIBROBLAST GROWTH FACTORS; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 4; HEP G2 CELLS; HUMANS; INSULIN; INSULIN RESISTANCE; LIVER; MICE;

EID: 84904817772     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Wang KA, Ding XH. Study on the epidemiological characteristics of diabetes mellitus and IGT in China [J]. Chin J Epidemiol, 1998, 19: 282-285.
2. Du WQ, Shi XF, Qiu MY, et al. Research progress of drugs for treatment of diabetes [J]. Chin Hosp Pharm J, 2005, 25: 70-72.
3. Li YM. A new anti-diabetes drug farglitazar [J]. Foreign Med Sci (Pharm), 2002, 29: 43-45.
4. Iglesias P, Selgas R, Romero S, et al. Biological role, clinical significance, and therapeutic possibilities of the recently discovered metabolic hormone fibroblastic growth factor 21 [J]. Eur J Endocrinol, 2012, 167: 301-309.
5. Sun GP, Ye XL, Ren GP, et al. The influence of fibroblast growth factor-21 on animal models of type 1 diabetes glycogen metabolism and its mechanism [J]. Prog Biochem Biophys 2011, 38: 953-960.
6. Ge X, Chen C, Hui XY, et al. Fibroblast growth factor 21 induces glucose transporter-1 expression through activation of the serum response factor/Ets-like protein-1 in adipocytes [J]. J Biol Chem, 2011, 286: 34533-34541.
7. Hou YT, Li JN, Ren GP, et al. Cloning, expression and glucose regulation activity of human FGF-21 [J]. Hereditas, 2010, 32: 583-587.
8. Zhang RX, Jia ZP, Li MX, et al. The establishment of insulin resistant model in vitro and preliminary application for screening drugs [J]. Chin Pharmacol Bull, 2008, 24: 971-976.
9. Liu MY, Wang WF, Yu YX, et al. Fibroblast growth factor-21 improves glucose uptake and glycogen synthesis of insulin-resistant liver cells [J]. Prog Biochem Biophys, 2009, 36: 1327-1333.
10. Zhu SL, Ren GP, Zhang ZY, et al. Therapeutic effect of fibroblast growth factor 21 on hypertension induced by insulin resistance [J]. Acta Pharm Sin, 2013, 48: 1409-1414.
11. Ye XL, Gao HS, Wang WF, et al. Optimization and characterization of a novel FGF-21 mutant [J]. Acta Pharm Sin, 2012, 47: 897-903.
12. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) [J]. Lancet, 1998, 352: 837-853.
13. Gao XR, Xu XH, Zan W, et al. Study progress on in diabetic treatment drug of insulin [J]. J Mil Surg in SW Chin, 2009, 9: 83-86.
14. Kharitonenkov A, Shiyanova TL, Koester A, et al. FGF-21 as a novel metabolic regulator [J]. J Clin Invest, 2005, 115: 1627-1635. (Pubitemid 40814671)
15. Magier Z, Jarzyna R. The role of glucose transporters in human metabolic regulation [J]. Postepy Biochem, 2013, 59: 70-82.
16. Hosaka T, Brooks CC, Presman E, et al. p115 interacts with the GLUT4 vesicle protein, IRAP, and plays a critical role in insulin-stimulated GLUT4 translocation [J]. Mol Biol Cell, 2005, 16: 2882-2890. (Pubitemid 40741232)
17. Ge X, Chen C, Hui XY, et al. Fibroblast growth factor 21 induces glucose transporter-1 expression through activation of the serum response factor/Ets-like protein-1 in adipocytes [J]. J Biol Chem, 2011, 286: 34533-34541.
18. Woo YC, Xu AM, Wang Y, et al. Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives [J]. Clin Endocrinol (Oxf), 2013, 78: 489-496.
19. Kong LJ, Feng W, Wright M, et al. FGF-21 suppresses hepatic glucose production through the activation of atypical protein kinase Cι/λ [J]. Eur J Pharmacol, 2013, 702: 302-308.
20. Liu M, Kong XX, Yang P, et al. Effect of fibroblast growth factor-21 on lipid metabolism of nonalcoholic fatty liver disease cell model induced in vitro [J]. J Jilin Univ (Med Ed), 2012, 38: 477-481, 611.